Optimization of vonoprazanâamoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study
Sign Up to like & getrecommendations! Published in 2022 at "Helicobacter"
DOI: 10.1111/hel.12896
Abstract: Vonoprazanâamoxicillin (VA) dual therapy has been shown to achieve acceptable cure rates for treatment of Helicobacter pylori(H. pylori) in Japan. Its effectiveness in other regions is unknown. We aimed to explore the efficacy of VA… read more here.
Keywords: therapy; dual therapy; vonoprazan amoxicillin; amoxicillin dual ... See more keywords
Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori
Sign Up to like & getrecommendations! Published in 2019 at "Digestion"
DOI: 10.1159/000502287
Abstract: Backgrounds/Aims: Vonoprazan (VPZ) is the first clinically available potassium competitive acid blocker. This class of agents provides faster and more potent acid inhibition than proton pump inhibitors. Most strains of Helicobacter pylori are sensitive to… read more here.
Keywords: eradication; dual therapy; vonoprazan amoxicillin; therapy ... See more keywords